Dozens of electronic dance music fans attending an Avicii concert in Boston had to be hospitalized Wednesday night, and several reports suggest ecstasy played a key role in their injuries.
Thirty-six people were taken to area hospitals and another 50 were treated at the scene, officials told ABC News.
"Signs of illicit drugs, including the popular club drug "Molly" — a form of ecstasy – were apparent, with concertgoers strapped to stretchers, some still screaming and flailing their arms," ABC News reported.
One concertgoer told TMZ that TD Garden, where the concert was held, smelled like marijuana and vomit.
"Some people were so wasted they were falling down stairs, urinating in the back rows, and passing out," the report said.
"There was a girl all alone, she was passed out for some time," Chad Dyson, who attended the concert with friends, told ABC News. "She was limp. Shortly after that, she started vomiting. They had EMS come by and actually took her away in a chair, strapped her down and took her out of the venue.
"I counted five separate ambulances and almost, they even had like a mobile command center set up as well, looked like a mobile command fire truck," he said.
Officials were unwilling to point the finger at ecstasy, or any other drug, and instead blamed alcohol and heat.
"There may have been some illicit drug involved, but none have been identified," said Boston EMS Deputy Superintendent Mike Bosse, Christian Science Monitor reported.
The Boston Police Licensing Division cited TD Garden for permitting intoxicated persons to enter, but the venue has refocused the public eye on the drug-permissive culture surrounding electronic dance music concerts, CSM reported.
Avicii, a Grammy-winning DJ from Sweden, took to his Twitter account after the hectic show.
"Its a terrible thing, I rly hope everyone is ok! My thoughts go to those affected & their families," he tweeted.
Twenty-nine people were hospitalized from drug- and alcohol-related illnesses at a Toronto concert by Avicii in May.
© Copyright 2016 The Washington Times, LLC. Click here for reprint permission.